Standard Chartered CEO Apologizes for LowerValue Human Capital Remark Amid AIDriven Job Cuts Patient Capital Trusts India as Hot Money Exits FDI Inflow Jumps 17 YoY to 945 Billion in FY26 SpaceXs Path to Public Markets Likely Tied to Starlink Revenue Growth IPO Filing Suggests Nvidia Earnings Spotlight Market Awaits Jensen Huangs Remarks on China Chip Restrictions and Geopolitical Outlook Kimi Antonelli Secures Historic Fourth Consecutive F1 Win in Canada Championship Standings Shift Wall Street Complacency Raises Concerns About Potential Market Correction Park Dental Partners Inc PARK Q1 2026 Earnings EPS Smashes Estimates Stock Gains on Strong Operational Performance Golden Entertainment Inc GDEN Q4 2025 Earnings Significant EPS Miss Amid Flat Revenue Disclosure Logitech LOGI Q1 2026 Earnings EPS Beats Estimates Amidst Cautious Market Response Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses ISBA Q1 2026 Earnings Massive EPS Miss Drives Stock Decline ADTN Q1 2026 Earnings EPS Surges Past Estimates Shares Rally 52 MARA Holdings MARA Declines 21 as Bitcoin Volatility Weighs on Mining Stocks Meritage Homes MTH Edges Higher as Homebuilder Sector Finds Footing Ares Capital ARCC Slips 08 as Investors Assess Yield and Rate Outlook T Stamp Inc IDAI Edges Lower Amid Consolidation Near Support Splash Beverage Group SBEV Slides 357 to 016 Testing Key Support at 015 Adherex Technologies Expands PEDMARK Focus to Adolescent and Young Adult Market After Record Quarter INCY Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline FMY Sees Modest Uptick Amid Stabilizing Mortgage Income Fund Performance SUZ Q1 2026 Earnings Strong EPS Surprise Amid Market Concerns TRGP Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions GRDX Q3 2024 Earnings Significant EPS Miss Amidst Operational Challenges VTAK Q1 2025 Earnings Significant EPS Miss Amidst Operational Challenges IONS Q1 2026 Earnings EPS Beat Drives Optimism as Pipeline Advances TRIB Q4 2024 Earnings Significant EPS Miss Despite Stock Uptick CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses